
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (05): 587-593.DOI: 10.12114/j.issn.1007-9572.2023.0924
Special Issue: 衰弱最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2024-04-10
Revised:2024-07-09
Published:2025-02-15
Online:2024-11-25
Contact:
MA Qing
通讯作者:
马清
作者简介:作者贡献:
石小天提出主要研究目标,负责研究的构思与设计,研究的实施,撰写论文;石小天、杨一帆、李旭、窦国泽进行数据的收集与整理,统计学处理,图、表的绘制与展示;王珊、杨华昱进行论文的修订;马清负责文章的质量控制与审查,对文章整体负责,监督管理。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0924
| 组别 | 例数 | 性别[例(%)] | 年龄[M(P25,P75),岁] | BMI [M(P25,P75),kg/m2] | 文化程度[例(%)] | 多重用药[例(%)] | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 高中以下 | 高中 | 大学及以上 | 是 | 否 | ||||
| 无衰弱组 | 341 | 259(75.95) | 82(24.05) | 71.0(65.0,80.0) | 24.37(22.42,26.21) | 7(2.05) | 23(6.74) | 311(91.20) | 85(24.93) | 256(75.07) |
| 衰弱/衰弱前期组 | 213 | 154(72.30) | 59(25.70) | 79.0(68.0,86.0) | 23.91(21.92,26.10) | 12(5.63) | 14(6.57) | 187(87.79) | 103(48.36) | 110(51.64) |
| 检验统计量值 | 0.920a | -6.166 | -1.398 | 5.078a | 32.104a | |||||
| P值 | 0.337 | <0.001 | 0.162 | 0.079 | <0.001 | |||||
| 组别 | 独居[例(%)] | 吸烟[例(%)] | 饮酒[例(%)] | MNA-SF评分[M(P25,P75),分] | ACCI [M(P25,P75),分] | 糖化血红蛋白[M(P25,P75),%] | ||||
| 是 | 否 | 是 | 否 | 是 | 否 | |||||
| 无衰弱组 | 28(8.21) | 313(91.79) | 46(13.49) | 295(86.51) | 109(31.96) | 232(68.04) | 14.00(13.00,14.00) | 3.00(2.00,4.00) | 5.97(5.67,6.42) | |
| 衰弱/衰弱前期组 | 19(8.92) | 194(91.08) | 28(13.15) | 185(86.85) | 54(25.35) | 159(74.65) | 13.00(12.00,14.00) | 4.00(3.00,5.00) | 5.89(5.60,6.24) | |
| 检验统计量值 | 0.085a | 0.013a | 2.761a | -4.920 | -6.569 | -1.768 | ||||
| P值 | 0.771 | 0.908 | 0.097 | <0.001 | <.001 | 0.077 | ||||
| 组别 | 白蛋白(g/L) | 白细胞计数[M(P25,P75),×109/L] | 中性粒细胞绝对值[M(P25,P75),×109/L] | 淋巴细胞绝对值[M(P25,P75),×109/L] | 单核细胞绝对值[M(P25,P75),×109/L] | 红细胞[M(P25,P75),×1012/L] | 血红蛋白[M(P25,P75),g/L] | |||
| 无衰弱组 | 44.07±2.57 | 6.14(5.28,7.25) | 3.47(2.81,4.30) | 2.21(1.71,2.65) | 0.29(0.23,0.38) | 4.73(4.46,4.96) | 148.00(140.00,155.00) | |||
| 衰弱/衰弱前期组 | 42.96±2.91 | 6.21(5.23,7.38) | 3.52(2.87,4.39) | 2.10(1.62,2.51) | 0.29(0.23,0.35) | 4.61(4.22,4.83) | 142.00(132.00,151.00) | |||
| 检验统计量值 | 4.169b | -0.115 | -0.817 | -2.497 | -0.732 | -3.786 | -4.856 | |||
| P值 | <0.001 | 0.909 | 0.414 | 0.013 | 0.464 | <0.001 | <0.001 | |||
| 组别 | 红细胞体积分布宽度[M(P25,P75),fL] | 血小板计数[M(P25,P75),×109/L] | 血小板体积分布宽度[M(P25,P75),%] | 总胆固醇[M(P25,P75),μmol/L] | 三酰甘油[M(P25,P75),μmol/L] | 高密度脂蛋白[M(P25,P75),μmol/L] | ||||
| 无衰弱组 | 43.60(41.70,45.20) | 211.00(183.00,244.00) | 11.50(10.70,12.50) | 4.80(4.20,5.57) | 1.26(0.98,1.71) | 1.19(1.03,1.37) | ||||
| 衰弱/衰弱前期组 | 44.30(42.60,45.90) | 206.00(172.00,244.00) | 11.50(10.40,12.50) | 4.65(3.85,5.45) | 1.14(0.85,1.68) | 1.23(1.02,1.48) | ||||
| 检验统计量值 | -2.702 | -1.541 | -0.868 | -2.560 | -2.896 | -1.030 | ||||
| P值 | 0.007 | 0.123 | 0.386 | 0.010 | 0.004 | 0.303 | ||||
| 组别 | 低密度脂蛋白[M(P25,P75),μmol/L] | NLR [M(P25,P75)] | dNLR [M(P25,P75)] | HRR [M(P25,P75)] | MLR [M(P25,P75)] | PLR [M(P25,P75)] | PRP [M(P25,P75)] | |||
| 无衰弱组 | 2.93(2.51,3.47) | 1.54(1.19,2.06) | 1.74(1.39,2.35) | 3.41(3.16,3.61) | 0.14(0.10,0.18) | 96.70(77.25,118.22) | 0.21(0.18,0.24) | |||
| 衰弱/衰弱前期组 | 2.67(2.19,3.26) | 1.73(1.30,2.31) | 2.00(1.53,2.63) | 3.23(2.97,3.48) | 0.14(0.11,0.19) | 96.40(79.61,124.30) | 0.21(0.18,0.27) | |||
| 检验统计量值 | -4.220 | -2.681 | -2.955 | -4.942 | -1.340 | -0.905 | -2.037 | |||
| P值 | <0.001 | 0.007 | 0.003 | <0.001 | 0.180 | 0.365 | 0.042 | |||
Table 1 Clinical features in the elderly of non-frail group versus frail/pre-frail group
| 组别 | 例数 | 性别[例(%)] | 年龄[M(P25,P75),岁] | BMI [M(P25,P75),kg/m2] | 文化程度[例(%)] | 多重用药[例(%)] | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 高中以下 | 高中 | 大学及以上 | 是 | 否 | ||||
| 无衰弱组 | 341 | 259(75.95) | 82(24.05) | 71.0(65.0,80.0) | 24.37(22.42,26.21) | 7(2.05) | 23(6.74) | 311(91.20) | 85(24.93) | 256(75.07) |
| 衰弱/衰弱前期组 | 213 | 154(72.30) | 59(25.70) | 79.0(68.0,86.0) | 23.91(21.92,26.10) | 12(5.63) | 14(6.57) | 187(87.79) | 103(48.36) | 110(51.64) |
| 检验统计量值 | 0.920a | -6.166 | -1.398 | 5.078a | 32.104a | |||||
| P值 | 0.337 | <0.001 | 0.162 | 0.079 | <0.001 | |||||
| 组别 | 独居[例(%)] | 吸烟[例(%)] | 饮酒[例(%)] | MNA-SF评分[M(P25,P75),分] | ACCI [M(P25,P75),分] | 糖化血红蛋白[M(P25,P75),%] | ||||
| 是 | 否 | 是 | 否 | 是 | 否 | |||||
| 无衰弱组 | 28(8.21) | 313(91.79) | 46(13.49) | 295(86.51) | 109(31.96) | 232(68.04) | 14.00(13.00,14.00) | 3.00(2.00,4.00) | 5.97(5.67,6.42) | |
| 衰弱/衰弱前期组 | 19(8.92) | 194(91.08) | 28(13.15) | 185(86.85) | 54(25.35) | 159(74.65) | 13.00(12.00,14.00) | 4.00(3.00,5.00) | 5.89(5.60,6.24) | |
| 检验统计量值 | 0.085a | 0.013a | 2.761a | -4.920 | -6.569 | -1.768 | ||||
| P值 | 0.771 | 0.908 | 0.097 | <0.001 | <.001 | 0.077 | ||||
| 组别 | 白蛋白(g/L) | 白细胞计数[M(P25,P75),×109/L] | 中性粒细胞绝对值[M(P25,P75),×109/L] | 淋巴细胞绝对值[M(P25,P75),×109/L] | 单核细胞绝对值[M(P25,P75),×109/L] | 红细胞[M(P25,P75),×1012/L] | 血红蛋白[M(P25,P75),g/L] | |||
| 无衰弱组 | 44.07±2.57 | 6.14(5.28,7.25) | 3.47(2.81,4.30) | 2.21(1.71,2.65) | 0.29(0.23,0.38) | 4.73(4.46,4.96) | 148.00(140.00,155.00) | |||
| 衰弱/衰弱前期组 | 42.96±2.91 | 6.21(5.23,7.38) | 3.52(2.87,4.39) | 2.10(1.62,2.51) | 0.29(0.23,0.35) | 4.61(4.22,4.83) | 142.00(132.00,151.00) | |||
| 检验统计量值 | 4.169b | -0.115 | -0.817 | -2.497 | -0.732 | -3.786 | -4.856 | |||
| P值 | <0.001 | 0.909 | 0.414 | 0.013 | 0.464 | <0.001 | <0.001 | |||
| 组别 | 红细胞体积分布宽度[M(P25,P75),fL] | 血小板计数[M(P25,P75),×109/L] | 血小板体积分布宽度[M(P25,P75),%] | 总胆固醇[M(P25,P75),μmol/L] | 三酰甘油[M(P25,P75),μmol/L] | 高密度脂蛋白[M(P25,P75),μmol/L] | ||||
| 无衰弱组 | 43.60(41.70,45.20) | 211.00(183.00,244.00) | 11.50(10.70,12.50) | 4.80(4.20,5.57) | 1.26(0.98,1.71) | 1.19(1.03,1.37) | ||||
| 衰弱/衰弱前期组 | 44.30(42.60,45.90) | 206.00(172.00,244.00) | 11.50(10.40,12.50) | 4.65(3.85,5.45) | 1.14(0.85,1.68) | 1.23(1.02,1.48) | ||||
| 检验统计量值 | -2.702 | -1.541 | -0.868 | -2.560 | -2.896 | -1.030 | ||||
| P值 | 0.007 | 0.123 | 0.386 | 0.010 | 0.004 | 0.303 | ||||
| 组别 | 低密度脂蛋白[M(P25,P75),μmol/L] | NLR [M(P25,P75)] | dNLR [M(P25,P75)] | HRR [M(P25,P75)] | MLR [M(P25,P75)] | PLR [M(P25,P75)] | PRP [M(P25,P75)] | |||
| 无衰弱组 | 2.93(2.51,3.47) | 1.54(1.19,2.06) | 1.74(1.39,2.35) | 3.41(3.16,3.61) | 0.14(0.10,0.18) | 96.70(77.25,118.22) | 0.21(0.18,0.24) | |||
| 衰弱/衰弱前期组 | 2.67(2.19,3.26) | 1.73(1.30,2.31) | 2.00(1.53,2.63) | 3.23(2.97,3.48) | 0.14(0.11,0.19) | 96.40(79.61,124.30) | 0.21(0.18,0.27) | |||
| 检验统计量值 | -4.220 | -2.681 | -2.955 | -4.942 | -1.340 | -0.905 | -2.037 | |||
| P值 | <0.001 | 0.007 | 0.003 | <0.001 | 0.180 | 0.365 | 0.042 | |||
| 因素 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| MNA-SF评分 | -0.34 | 0.08 | -4.36 | <0.001 | 0.71(0.61~0.83) |
| ACCI | 0.35 | 0.08 | 4.33 | <0.001 | 1.42(1.21~1.66) |
| HRR | -0.81 | 0.34 | -2.40 | 0.016 | 0.44(0.23~0.86) |
| 多重用药(以是为参考) | |||||
| 否 | -0.62 | 0.21 | -2.93 | 0.003 | 0.54(0.36~0.81) |
Table 2 Multivariate Logistic regression analysis on influencing factors of frailty/pre-frailty in the elderly
| 因素 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| MNA-SF评分 | -0.34 | 0.08 | -4.36 | <0.001 | 0.71(0.61~0.83) |
| ACCI | 0.35 | 0.08 | 4.33 | <0.001 | 1.42(1.21~1.66) |
| HRR | -0.81 | 0.34 | -2.40 | 0.016 | 0.44(0.23~0.86) |
| 多重用药(以是为参考) | |||||
| 否 | -0.62 | 0.21 | -2.93 | 0.003 | 0.54(0.36~0.81) |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
中华医学会老年医学分会,《中华老年医学杂志》编辑委员会. 老年人衰弱预防中国专家共识(2022)[J]. 中华老年医学杂志,2022,41(5):503-511. DOI:10.3760/cma.j.issn.0254-9026.2022.05.001.
|
| [13] |
中国老年医学学会营养与食品安全分会,中国循证医学中心,《中国循证医学杂志》编辑委员会,等. 老年患者家庭营养管理中国专家共识(2017版)[J]. 中国循证医学杂志,2017,17(11):1251-1259. DOI:10.7507/1672-2531.201707095.
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [1] | LI Jiao, XIANG Qingwei, LIU Jinjin, PENG Lang, ZHOU Jianjie, YANG Qiong, MEI Yingbing, LIU Hui, FANG Yingsong, TAN Zihu. Development and Validation of Risk Prediction Model for Fall-related Hospitalization in Patients with Alzheimer's Disease [J]. Chinese General Practice, 2026, 29(32): 4721-4729. |
| [2] | PANG Shu, LI Xingming, BAI Hongmei, JIANG Chunyan. Conceptualization of Pre-frailty and Perspectives on Its Screening and Management among Community-dwelling Older Adults with Pre-frailty: a Semi-Structured Interview Study [J]. Chinese General Practice, 2026, 29(31): 4600-4608. |
| [3] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [4] | LI Jiao, ZHOU Jianjie, PENG Lang, MEI Yingbing, TAN Zihu. Development and Validation of a Risk Prediction Model for Poor Prognosis in Alzheimer's Disease Patients with Community-acquired Pneumonia [J]. Chinese General Practice, 2026, 29(29): 4248-4257. |
| [5] | LIU Zhenyu, WANG Wendong, YAO Qing, WANG Jiangmin, CAO Wendong. Analysis of Prevalence and Influencing Factors of Cardiovascular-kidney-metabolic Syndrome among Adults in Haidian District, Beijing [J]. Chinese General Practice, 2026, 29(27): 3969-3975. |
| [6] | ZHANG Xuechao, QI Qi, WU Xinyu, HAN Quanle, LI Lei, DENG Jie, LI Cangtuo, YUE Bocheng, WU Shouling, LI Kangbo. Association between the Atherogenic Index of Plasma and New-onset Chronic Kidney Disease [J]. Chinese General Practice, 2026, 29(24): 3440-3446. |
| [7] | YUAN Hangtao, HONG Yan, YUAN Peihong, LIN Bo, CUI Xiaoyun, LI Weiwei. Interpretable Machine Learning Models for Predicting the Risk of Incident Cardiometabolic Multimorbidity in Chinese Postmenopausal Women [J]. Chinese General Practice, 2026, 29(23): 3294-3306. |
| [8] | WANG Xinliang, ZOU Nannan, CHEN Nana, WANG Xin. Analysis of Clinical Characteristics and Prognostic Risk Factors in Patients with Pulmonary Mucormycosis Complicated with Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(22): 3154-3161. |
| [9] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [10] | SONG Zhenzhen, CHEN Yang, WANG Jiwen, LIU Huishan, SHEN Simeng, SUN Ying, CHEN Xing. Study of Maternal Risk Factors Associated with Neonatal Asphyxia in Late Preterm and Term Infants [J]. Chinese General Practice, 2026, 29(20): 2874-2878. |
| [11] | LI Chaohui, LIU Hui, WANG Kai. Identification of Factors Associated with Persistent Atrial Fibrillation and Development of a Classification Model [J]. Chinese General Practice, 2026, 29(20): 2846-2853. |
| [12] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [13] | ZHANG Huifang, CHEN Cunchuan, FAN Boyang, SUN Wenning, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study on the Service Capability of Primary Care Doctors to Integrate Medical and Preventive Services and Its Influencing Factors in Shandong Province [J]. Chinese General Practice, 2026, 29(19): 2711-2716. |
| [14] | ZHAO Huili, LU Lina, ZHUO Ya, WANG Xin. Clinical Characteristics and Risk Factors for Recurrence of Cryptogenic Organizing Pneumonia [J]. Chinese General Practice, 2026, 29(19): 2648-2655. |
| [15] | PANG Shu, SUN ying, JIANG Chunyan. Comparison of the Effectiveness of Fried's Frailty Phenotype and the FRAIL Scale in Assessing Pre-frailty among Community-dwelling Older Adults Undergoing Health Examinations [J]. Chinese General Practice, 2026, 29(19): 2664-2670. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||